Evidence map›Paper›PMID 35771252›Full record

ArticleIntensive care medicine2022

Ventilator-associated pneumonia.

Otavio T Ranzani, Michael S Niederman, Antoni Torres

Registry-linked trialAbstract readEditorial
In one paragraph

Article in Intensive care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06834971 (Colistin Methanesulfonate Sodium Inhalation for Prophylaxis of Ventilator-Associated Pneumonia), which is not on this map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06834971 narecruitingnot on this mapstarted 2025, after this paper: background citation

Colistin Methanesulfonate Sodium Inhalation for Prophylaxis of Ventilator-Associated Pneumonia (CIVAP): A Prospective, Multicentre, Double-Blind, Randomized, Placebo-Controlled Trial

TypeinterventionalSponsorQilu Hospital of Shandong UniversityRan2025 to 2026Enrolled508ConditionsVentilator-Associated Pneumonia (VAP)ArmsColistimethate sodium (CMS)
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Intravenous combined with nebulized polymyxin B may be effective in treating carbapenem-resistant gram-negative bacilli hospital-acquired pneumonia: a retrospective cohort study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Otavio T RanzaniBarcelona Institute for Global Health, ISGlobal, Universitat Pompeu Fabra (UPF), CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.ORCID http://orcid.org/0000-0002-4677-6862
Michael S NiedermanDepartment of Pulmonary and Critical Care Medicine, Weill Cornell Medicine, New York Presbyterian/Weill Cornell Medical Center, New York, NY, USA. msn9004@med.cornell.edu.
Antoni TorresDepartment of Pneumology, Institut Clinic de Respiratori, Hospital Clinic of Barcelona, Ciber de Enfermedades Respiratorias (Ciberes, CB06/06/0028), Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), ICREA, University of Barcelona (UB), Barcelona, Spain.

Funding

Instituto de Salud Carlos III CEX2018-000806-S
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Pneumonia, Ventilator-AssociatedHumansIntensive Care Units

Identifiers

PMID35771252
PMCPMC9245883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.